Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting

During routine authentication checks, we noticed untoward karyotypic similarities between late-passage stocks of the Dami megakaryocyte and HEL erythroleukemia cell lines. Genetic identity of Dami with HEL was demonstrated by DNA fingerprinting with a (gtg)5 multilocus probe and confirmed for earlier passages of Dami deposited by its originators with the ATCC. As initial passage stocks of Dami are no longer available for comparison, we investigated whether cross-contamination by HEL was more likely to have occurred during Dami’s establishment or subsequently, by karyotyping currently available stocks of both cell lines for comparison with that originally reported for Dami. We found that the karyotype of current stocks of Dami overwhelmingly resembles that described in the original report, having retained at least 16/18 structural chromosome rearrangements as described therein, cf. 12/20 shared by current stocks of Dami and HEL. HEL’s antecedence is shown by the retention of normal homologs of chromosomes, 6, 18, and 21 – all rearranged in Dami. These results confirm the identity of current and early passage stocks of Dami and their common origin by cross-contamination with HEL which had occurred by July 1987, a year prior to publication. Thus, most, if not all, studies using Dami are likely to have employed HEL instead and may require reappraisal.

[1]  J. Launay,et al.  Platelet receptor expression on three human megakaryoblast-like cell lines. , 1992, Experimental hematology.

[2]  J. Amiral,et al.  Carboxy‐terminal peptides (C1–24 and C13–24 but not C1–13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin , 1996, British journal of haematology.

[3]  M. Kroll,et al.  Molecular Cloning of a Novel Platelet Protein Showing Homology to the Angiotensin II Receptor C-terminal Domain (*) , 1996, The Journal of Biological Chemistry.

[4]  V. Kakkar,et al.  Expression of human TRPC genes in the megakaryocytic cell lines MEG01, DAMI and HEL , 1997, FEBS letters.

[5]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[6]  S. Rafii,et al.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B Budowle,et al.  Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. , 1991, American journal of human genetics.

[8]  L. Kapural,et al.  Suppression of the delayed rectifier type of voltage gated K+ outward current in megakaryocytes from patients with myelogenous leukemias. , 1995, Blood.

[9]  M. B. Feinstein,et al.  Purification and characterization of the human type 1 Ins(1,4,5)P3 receptor from platelets and comparison with receptor subtypes in other normal and transformed blood cells. , 1995, Biochemical Journal.

[10]  B. Mccarthy,et al.  High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. , 1989, American journal of human genetics.

[11]  S. Surrey,et al.  Human c-kit ligand (stem cell factor) induces platelet Fc receptor expression in megakaryoblastic cells. , 1996, Experimental hematology.

[12]  J. Ylänne,et al.  Expression of megakaryocytic and erythroid properties in human leukemic cells. , 1996, Experimental hematology.

[13]  C. Dang,et al.  Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. , 1995, Blood.

[14]  T. Chen,et al.  Cell line banks and their role in cancer research , 1996, Journal of cellular biochemistry. Supplement.

[15]  A. Gewirtz,et al.  Identification of Gz alpha as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes. , 1991, Blood.

[16]  K. Klinger,et al.  Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. , 1989, Nucleic acids research.

[17]  D. Rosenthal,et al.  Characterization of a new megakaryocytic cell line: the Dami cell. , 1988, Blood.

[18]  Z. Estrov,et al.  Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. , 1995, The American journal of medicine.

[19]  H. Drexler,et al.  c-kit Expression in Human Megakaryoblastic Leukemia Cell Lines , 1994 .

[20]  H. Drexler,et al.  Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. , 1996, Leukemia.

[21]  D. Birnbaum,et al.  Expression of the FLT3 gene in human leukemia-lymphoma cell lines. , 1994, Leukemia.

[22]  W. Vainchenker,et al.  Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines. , 1991, Experimental hematology.

[23]  C. Vesin,et al.  Activated human platelets express beta2 integrin. , 1996, European journal of haematology.

[24]  Y. Hong,et al.  Antimicrotubule agents induce polyploidization of human leukaemic cell lines with megakaryocytic features , 1993, European journal of clinical investigation.

[25]  K. Alitalo,et al.  FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. , 1992, Cancer research.

[26]  J. Caen,et al.  Interleukin‐3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG‐01 cells , 1994, British journal of haematology.

[27]  M. Fey,et al.  Expression and regulation of G1 cell-cycle inhibitors (p16INK4A , p15INK4B, p18 INK4C, p19INK4D ) in human acute myeloid leukemia and normal myeloid cells , 1997, Leukemia.